Xinya Tong

Wenzhou Key Laboratory Of Cancer Related Pathogens And Immunity
Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

METTL3-targeted intervention on nuclear factors RORA/RORγt suppresses pathogenic T helper 17 cell differentiation and alleviates kidney damage in lupus nephritis.

METTL3-targeted intervention on nuclear factors RORA/RORγt suppresses pathogenic T helper 17 cell differentiation and alleviates kidney damage in lupus nephritis.

Journal: Kidney international

Published: September 25, 2025

NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB-STAT3 signalling in a non-m5C manner.

NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB-STAT3 signalling in a non-m5C manner.

Journal: Clinical and translational medicine

Published: October 01, 2024

Correction: NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.

Correction: NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.

Journal: Cell death & disease

Published: July 11, 2024

5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.

5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.

Journal: Lupus science & medicine

Published: June 17, 2024

RNA epigenetic modifications in digestive tract cancers: Friends or foes.

RNA epigenetic modifications in digestive tract cancers: Friends or foes.

Journal: Pharmacological research

Published: April 24, 2024

Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.

Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.

Journal: Frontiers in pharmacology

Published: December 07, 2023

RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.

RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.

Journal: Wiley interdisciplinary reviews. RNA

Published: November 01, 2022

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma.

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma.

Journal: Frontiers in immunology

Published: January 27, 2022

Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance.

Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance.

Journal: Molecular therapy. Nucleic acids

Published: October 11, 2021

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma.

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma.

Journal: Frontiers in oncology

Published: October 03, 2021

Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.

Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.

Journal: Journal of inflammation research

Published: July 30, 2021

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.

Journal: Cell death & disease

Published: March 20, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026